Judging disease activity in rheumatoid arthritis by serum free kappa and lambda light chain levels

Kaohsiung Journal of Medical Sciences

Volumn 29, Issue 10, 2013, Pages 547-553

  Ye, Yun ^a   Li, Su Liang ^a   Xie, Ming ^b   Jiang, Ping ^a   Liu, Kai Ge ^a   Li, Ya Jun ^a  

^a XI'AN MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Disease activity; Disease activity score; Light chain; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN ANTIBODY; RHEUMATOID FACTOR;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; RECEIVER OPERATING CHARACTERISTIC; REMISSION; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT;

DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; LIGHT CHAIN; RHEUMATOID ARTHRITIS;

ADULT; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 84885182973     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.kjms.2013.01.013     Document Type: Article

References (21)

1. N. Komatsu, and H. Takayanagi Inflammation and bone destruction in arthritis: synergistic activity of immune and mesenchymal cells in joints Front Immunol 3 2012 77
2. J. Jacob, D. Sartoris, S. Kursunoglu, D. Pate, C.J. Pineda, and R.M. Braun Distal interphalangeal joint involvement in rheumatoid arthritis Arthritis Rheum 29 1986 10 15
3. T.T. Mottonen Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis Ann Rheum Dis 47 1988 648 653
4. G. Clavel, N. Bessis, and M.C. Boissier Recent data on the role for angiogenesis in rheumatoid arthritis Joint Bone Spine 70 2003 321 326
5. T. Dorner, and G.R. Burmester The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets Curr Opin Rheumatol 15 2003 246 251
6. S. Lindenau, S. Scholze, M. Odendahl, T. Dörner, A. Radbruch, and G.R. Burmester Aberrant activation of B cells in patients with rheumatoid arthritis Ann N Y Acad Sci 98 2003 246 248
7. G.Y. Shi Arthritis overview 2005 China Medical Science Press Beijing
8. F.C. Arnett, S.M. Edworthy, D.A. Bloch, D.J. McShane, J.F. Fries, and N.S. Cooper The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 1988 315 324
9. B. Vander Cruyssen, S. Van Looy, B. Wyns, R. Westhovens, P. Durez, and F. Van den Bosch DAS28 best reflects the physician's clinical judgement of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment Arthritis Res Ther 7 2005 1063 1071
10. D.M. van der Heijde, M.A. van 't Hof, P.L. van Riel, L.A. Theunisse, E.W. Lubberts, and M.A. van Leeuwen Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score Ann Rheum Dis 49 1990 916 920
11. R. Khurana, and S.M. Berney Clinical aspects of rheumatoid arthritis Pathophysiology 12 2005 153 165
12. G.S. Firestein, and N.J. Zvaifler How important are T cells in chronic rheumatoid synovitis? II. T cell-independent mechanisms from beginning to end Arthritis Rheum 46 2002 298 308
13. M. Nelson, R.D. Brown, J. Gibson, and D.E. Joshua Measurement of free kappa and lambda chains in serum and the significance of their ratio in patients with multiple myeloma Br J Haematol 81 1992 223 230
14. X.W. Cao, B.H. Ju, and B.H. Song Detection of free κ〠λ light chain in human serum Pract Clin Med 5 2004 13 14
15. R.A. Levy, A.E. Gharavi, L.R. Sammaritano, L. Habina, T. Qamar, and M.D. Lockshin Characteristics of IgG antiphospholipid antibodies in patients with systemic lupus erythematosus and syphilis J Rheumatol 17 1990 1036 1041
16. C. Demaison, C.T. Ravirajan, D.A. Isenberg, and M. Zouali Analysis of variable region genes encoding anti-Sm and anti-cardiolipin antibodies from a systemic lupus erythematosus patient Immunology 86 1995 487 494
17. S.P. Moyes, R.N. Maini, and R.A. Mageed Differential use of immunoglobulin light chain genes and B lymphocyte expansion at sites of disease in rheumatoid arthritis (RA) compared with circulating B lymphocytes Clin Exp Immunol 113 1998 276 288
18. J.E. Gottenberg, F. Aucouturier, J. Goetz, C. Sordet, I. Jahn, and M. Busson Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome Ann Rheum Dis 66 2007 23 27
19. F. Salaffi, M. Peroni, and G.F. Ferraccioli Discriminating ability of composite indices for measuring disease activity in rheumatoid arthritis: a comparison of the Chronic Arthritis Systemic index, Disease Activity score and Thompson's Articular Index Rheumatology 39 2000 90 96
20. S. Agrawal, R. Misra, and A. Aggarwal Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA Clin Rheumatol 26 2007 201 204
21. D. Marasovic-Krstulovic, D. Martinovic-Kaliterna, D. Fabijanic, and J. Morovic-Vergles Are the anti-cyclic citrullinated peptide antibodies independent predictors of, myocardial involvement in patients with active rheumatoid arthritis? Rheumatology (Oxford) 50 2011 1505 1512